29 |
Characterization of a Murine Intestinal Cancer Homograft Model for Therapeutic EvaluationSession Date and Time: Session Category: Tumor Biology |
|
52 |
Characterization of Murine Intrahepatic Cholangiocarcinoma Homograft Models for Therapeutic EvaluationSession Date and Time: Session Category: Tumor Biology |
|
185 |
Global Mapping of Pathway Modules and Phosphorylation Networks in PDX and Corresponding Organoid (PDXO) Models Treated with Targeted TherapiesSession Date and Time: |
|
198 |
Pan-cancer Assay-ready Organoid Drug Screening with Robust, Reproducible and Clinically-relevant OutputSession Date and Time: |
|
401 |
Developing KRAS G12C Inhibitor-resistant Tumor Models for Efficacy Evaluation of Next-generation Anticancer TherapiesSession Date and Time: |
|
497 |
HX301, a First-in-class ARK5i, Demonstrates Antitumor Activity in Preclinical HCC Models with High ARK5/Myc ExpressionSession Date and Time: Session Category: Experimental and Molecular Therapeutics |
|
579 |
Mini-tumors: Preclinical HCI Assays to Screen Anti-cancer Drugs in the Context of Organoids, Cancer-associated Fibroblasts and Immune CellsSession Date and Time: Session Category: Experimental and Molecular Therapeutics |
|
2053 |
Structural Variants Detected by Optical Genome Mapping in Acute Lymphoblastic Leukemia Patient-Derived Xenograft ModelsSession Date and Time: Session Category: Bioinformatics / Computational Biology / Systems Biology / Convergent Science |
|
2387 |
Characterization of Orthotopic Bioluminescent Patient-derived Xenografts Model of Glioma for Drug DiscoverySession Date and Time: Session Category: Tumor Biology |
|
2822 |
Maximizing Radiotherapy Impact: A Novel Preclinical Platform for Screening of Radiosensitizing Agents in Patient-derived Tumor OrganoidsSession Date and Time: Session Category: Experimental and Molecular Therapeutics |
|
2980 |
HX009, a First-in-class PD1xCD47 BsAb, Demonstrated Anti-AML Activity in PDX Models
Session Date and Time: Session Category: Immunology |
|
4146 |
Unlocking IO Drug Potential by High Content Imaging of Immune Cell Co-cultures with Cancer Organoids from Diverse Cancer IndicationsSession Date and Time: Session Category: Immunology |
|
4168 |
BALB/c-CD3EDG HuGEMM™ Mouse Model for Evaluation of CD3-targeted Tumor ImmunotherapySession Date and Time: Session Category: Immunology |
|
4570 |
Expanding the 3D Ex Vivo Patient Tissue Platform Toolbox for Immuno-Oncology Drug TestingSession Date and Time: Session Category: Tumor Biology |
|
4679 |
Molecular Pathology and BTKi Pharmacology of DLBCL PDX ModelsSession Date and Time: Session Category: Tumor Biology |
|
5118 |
STING Agonist and TLR7/8 Agonist Overcome Anti-PD-1 Resistance Mediated by Loss of β2MSession Date and Time: |
|
5133 |
Evaluation of an Anti-huIL4Rα mAb in the OXA-Induced Atopic Dermatitis Model in hIL4/hIL4α Double-KI (C57BL/6) MiceSession Date and Time: Session Category: Immunology |
|
5134 |
PD-1/PD-L1 Signaling Axis, “A Double-edged Sword” in a DSS-Induced Colitis Mouse ModelSession Date and Time: |
|
6592 |
An AI Platform for Vascular and Fibrosis Analysis of Pathology ImagesSession Date and Time: Session Category: Bioinformatics / Computational Biology / Systems Biology / Convergent Science |
|
6775 |
Indivumed Services - Combination of Spatial Transcriptomics and Multiplex IHC as Valuable Multi-Omics Tool for Biomarker DiscoverySession Category: Biomarkers |
Your privacy is important to us.
We'll never share your information.
© 2023 Crown Bioscience. All Rights Reserved.
© 2023 Crown Bioscience. All Rights Reserved. Privacy Policy